ALLISON BUNNELL: Open Payments
NPI 1861800013 · OWEGO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$515 in 26 payments from 14 companies in 2025. Trend: 2023 $266 · 2024 $335 · 2025 $515
Food & beverage: $515
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $112 |
| Janssen Pharmaceuticals, Inc | 2 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $63 |
| ABBVIE INC. | 2 | $54 |
| Exact Sciences Corporation | 2 | $48 |
| PFIZER INC. | 2 | $35 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $21 |
| Amgen Inc. | 1 | $19 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
Products named: REXULTI, INVEGA SUSTENNA, CAPLYTA, VRAYLAR, PREVNAR 20, ABILIFY MAINTENA, Cologuard Collection Kit, FANAPT.
Industry payments across NY — which companies pay providers there.
